Carl Zeiss Meditec (ETR:AFX) has been given a €48.00 ($57.14) target price by analysts at Deutsche Bank in a research note issued to investors on Thursday. The brokerage currently has a “neutral” rating on the stock. Deutsche Bank’s price target suggests a potential downside of 8.40% from the stock’s previous close.

AFX has been the topic of a number of other reports. set a €52.00 ($61.90) target price on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Friday, November 10th. Commerzbank set a €42.00 ($50.00) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 8th. Independent Research set a €54.00 ($64.29) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 8th. Berenberg Bank set a €48.00 ($57.14) target price on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Wednesday, September 20th. Finally, Nord/LB set a €60.00 ($71.43) target price on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Tuesday. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. Carl Zeiss Meditec has a consensus rating of “Hold” and a consensus price target of €50.36 ($59.95).

Carl Zeiss Meditec (ETR AFX) opened at €52.40 ($62.38) on Thursday. Carl Zeiss Meditec has a one year low of €32.14 ($38.26) and a one year high of €53.35 ($63.51).

WARNING: This article was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and republished in violation of United States & international copyright and trademark laws. The legal version of this article can be read at https://www.americanbankingnews.com/2017/12/14/carl-zeiss-meditec-afx-pt-set-at-48-00-by-deutsche-bank.html.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Devices and Microsurgery segments. The Ophthalmic Devices segment offers optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.